Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"

Valuation: DANAHER

Market Cap 128B 110B 102B 95.48B 179B 12,126B 181B 1,199B 468B 5,933B 481B 471B 20,558B P/E Ratio 2026 *
28.9x
P/E Ratio 2027 * 22.9x
Enterprise Value 137B 118B 109B 102B 192B 12,980B 194B 1,284B 501B 6,351B 515B 504B 22,006B EV / Sales 2026 *
5.25x
EV / Sales 2027 * 4.66x
Free-Float
71.13%
Yield 2026 *
0.79%
Yield 2027 * 0.85%
Manager TitleAgeSince
Chief Executive Officer 62 2020-08-31
Director of Finance/CFO - 2026-02-27
Chief Tech/Sci/R&D Officer - 2025-08-24
Director TitleAgeSince
Director/Board Member 74 1999-06-30
Chairman 74 1983-12-31
Director/Board Member 69 1983-12-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-1.98% - - 128B
-0.23%+0.64%+17.35%-11.68% 176B
+0.12%-0.37%-18.57%+27.05% 148B
+0.34%-3.66%-52.96%-13.08% 69.5B
+2.67%+3.18%+17.87%-2.97% 49.68B
+0.97%+2.71%-22.67%-32.79% 45.26B
-1.72%-3.28%+9.62%+5.86% 36.88B
+0.78%-0.77%+5.33%+34.48% 35.13B
-2.36%-2.23%-12.48%-20.06% 29.46B
+0.62%+0.41%-22.22%-11.43% 27.84B
Average +0.11%-0.79%-8.75%-2.73% 68.59B
Weighted average by Cap. +0.11%-0.49%-6.40%-0.14%

Financials

2026 *2027 *
Net sales 26.13B 22.51B 20.71B 19.46B 36.54B 2,472B 36.98B 244B 95.33B 1,209B 98.04B 95.96B 4,190B 28.56B 24.61B 22.64B 21.28B 39.95B 2,702B 40.43B 267B 104B 1,322B 107B 105B 4,581B
Net income 4.38B 3.78B 3.48B 3.27B 6.13B 415B 6.21B 41.02B 16B 203B 16.45B 16.1B 703B 5.53B 4.76B 4.38B 4.12B 7.73B 523B 7.83B 51.73B 20.18B 256B 20.75B 20.31B 887B
Net Debt 9.02B 7.77B 7.15B 6.72B 12.62B 854B 12.77B 84.42B 32.93B 418B 33.86B 33.14B 1,447B 4.92B 4.24B 3.9B 3.67B 6.89B 466B 6.97B 46.07B 17.97B 228B 18.48B 18.09B 790B
Logo DANAHER
Danaher Corporation is an industrial and technologic group organized around three families of products: - diagnostic equipment (40.5% of net sales); - life sciences equipment (29.8%); - biotechnology equipment (29.7%): ranging from basic biological research to the development and manufacturing of vaccines, biological drugs, cell and gene therapies, and new technologies such as mRNA. Net sales are distributed geographically as follows: the United States (40.6%), China (10.7%) and other (48.7%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!